Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024GlobeNewsWire • 07/15/24
Organogenesis Holdings Inc. to Participate in the Truist Securities MedTech ConferenceGlobeNewsWire • 06/06/24
Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee OsteoarthritisGlobeNewsWire • 05/02/24
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024GlobeNewsWire • 04/16/24
Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud CaseGlobeNewsWire • 04/03/24
Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 GuidanceGlobeNewsWire • 02/29/24
Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools ConferenceGlobeNewsWire • 02/12/24
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024GlobeNewsWire • 02/08/24
Are You Looking for a Top Momentum Pick? Why Organogenesis (ORGO) is a Great ChoiceZacks Investment Research • 01/15/24
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmBusiness Wire • 12/07/23
Here Is Why Bargain Hunters Would Love Fast-paced Mover Organogenesis (ORGO)Zacks Investment Research • 11/30/23
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023GlobeNewsWire • 10/05/23
Organogenesis Applauds Withdrawal of Local Coverage Determinations by Novitas, First Coast Service Options and CGSGlobeNewsWire • 09/28/23
Organogenesis Holdings Inc. to Participate in the Morgan Stanley 21st Annual Global Healthcare ConferenceGlobeNewsWire • 09/06/23